- Home
- BNOX
as 07-26-2024 4:00pm EST
Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.
| Founded: | 1996 | Country: | Australia |
| Employees: | N/A | City: | N/A |
| Market Cap: | 11.0M | IPO Year: | 2021 |
| Target Price: | $9.00 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 32.79 | EPS Growth: | 256.41 |
| 52 Week Low/High: | $0.65 - $6.41 | Next Earning Date: | 01-01-0001 |
| Revenue: | $14,998 | Revenue Growth: | -91.64% |
| Revenue Growth (this year): | 4308.9% | Revenue Growth (next year): | 52.77% |
Latest Bionomics Limited American Depository Shares News
BNOX Breaking Stock News: Dive into BNOX Ticker-Specific Updates for Smart Investing
GlobeNewswire
9 days ago
Bionomics Initiates AFFIRM-1, a Phase 3 Clinical Trial with BNC210 for Social Anxiety Disorder
Yahoo Finance Video
2 months ago
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
GlobeNewswire
2 months ago
Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis
Reuters
2 months ago
California seeks company profits in Big Oil climate lawsuit
USA TODAY
2 months ago
S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead
GlobeNewswire
2 months ago
Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis
Business Wire
2 months ago
Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
Business Wire
2 months ago
Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas
Compare BNOX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BNOX Bionomics Limited American Depository Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.